Besides, cell populations participated in anti-tumor immune response, such as, immature B cell, central memory CD4 T cell, type 17 T helper cell, central memory CD8 T cell, CD56 bright killer cell, effector memory CD8 T cell, nature killer cell, and nature killer T cell, were all markedly reduced in high-risk score group. This evidence concerns the gene NCAM1 and neoplasm.